SXTC
NASDAQ
CN
China SXT Pharmaceuticals, Inc. - Common Stock
$1.89
▲ +$0.09
(+5.00%)
Vol 68K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$185.6M
ROE
-21.7%
Margin
-189.8%
D/E
5.23
Beta
1.62
52W
$1–$8
Price Chart
Similar Stocks
Fundamentals Trend
| Metric | 2025-03-31 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -21.7% | 40.0% | -21.7% | -21.7% | -21.7% | -21.7% |
| P/E (TTM) | — | 31.23 | — | — | — | — |
| Net Margin | -274.4% | 318.7% | -189.8% | -189.8% | -189.8% | -189.8% |
| Gross Margin | 25.5% | 22.0% | 21.1% | 21.1% | 21.1% | 21.1% |
| D/E Ratio | 5.23 | 14.71 | 5.23 | 5.23 | 5.23 | 5.23 |
| Current Ratio | 3.54 | 1.40 | 3.54 | 3.54 | 3.54 | 3.54 |
Key Ratios
ROA (TTM)
-12.6%
P/S (TTM)
106.64
P/B
0.1
EPS (TTM)
$-3.01
CF/Share
$-21.29
Rev Growth 3Y
-12.5%
52W High
$7.84
52W Low
$0.95
$0.95
52-Week Range
$7.84
How does SXTC compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
SXTC valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
106.6
▲
2054%
above
peers
(5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
0.1
▼
94%
below
peers
(2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
SXTC profitability vs Pharmaceuticals peers
ROE
-21.7%
▲
60%
above
peers
(-54.3%)
vs Peers
vs Industry
Below avg
Net margin
-189.8%
▼
301%
below
peers
(-47.4%)
vs Peers
vs Industry
Weak
Gross margin
21.1%
▼
69%
below
peers
(68.3%)
vs Peers
vs Industry
Weak
ROA
-12.6%
▲
66%
above
peers
(-37.4%)
vs Peers
vs Industry
Below avg
SXTC financial health vs Pharmaceuticals peers
D/E ratio
5.2
▲
240%
above
peers
(1.5)
vs Peers
vs Industry
Above avg
Current ratio
3.5
▲
5%
above
peers
(3.4)
vs Peers
vs Industry
In line
Beta
1.6
▲
72%
above
peers
(0.9)
vs Peers
vs Industry
More volatile
SXTC fundamentals radar
SXTC
Peer median
Industry
SXTC profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
SXTC vs peers: key metrics
Latest News
No related news yet